Negocie de forma mais inteligente, não mais difícil: Libere seu potencial com nosso conjunto de ferramentas e discussões ao vivo.
Cardiol Therapeutics Inc. (NASDAQ: CRDL) (TSX: CRDL) is a clinical-stage life sciences company focused on the research and clinical development of anti-inflammatory and anti-fibrotic therapies for the treatment of heart disease. The Company's lead drug candidate, CardiolRxTM (cannabidiol) oral solut... Cardiol Therapeutics Inc. (NASDAQ: CRDL) (TSX: CRDL) is a clinical-stage life sciences company focused on the research and clinical development of anti-inflammatory and anti-fibrotic therapies for the treatment of heart disease. The Company's lead drug candidate, CardiolRxTM (cannabidiol) oral solution, is pharmaceutically manufactured and in clinical development for use in the treatment of heart disease. It is recognized that cannabidiol inhibits activation of the inflammasome pathway, an intracellular process known to play an important role in the development and progression of inflammation and fibrosis associated with myocarditis, pericarditis, and heart failure. Mostrar mais
Pergunte à ADVFN Intelligence (IA)
| Período | Var | Var % | Abe | Máx. | Mín. | Vol Méd. | VWAP diário | |
|---|---|---|---|---|---|---|---|---|
| 1 | -0.205 | -10.4591836735 | 1.96 | 2.01 | 1.56 | 312134 | 1.93961788 | CS |
| 4 | -0.335 | -16.028708134 | 2.09 | 2.63 | 1.56 | 398040 | 2.19803586 | CS |
| 12 | -0.385 | -17.9906542056 | 2.14 | 2.63 | 1.56 | 298199 | 2.11634372 | CS |
| 26 | -0.135 | -7.14285714286 | 1.89 | 3.12 | 1.55 | 392309 | 2.20919234 | CS |
| 52 | 0.9205 | 110.305572199 | 0.8345 | 3.12 | 0.661 | 343973 | 1.82549723 | CS |
| 156 | -1.476 | -45.6824512535 | 3.231 | 4.96 | 0.45 | 300214 | 1.82172892 | CS |
| 260 | -0.875 | -33.2699619772 | 2.63 | 4.96 | 0.45 | 322296 | 2.06169074 | CS |
Suporte: (11) 4950 5808 | suporte@advfn.com.br
Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições
Recursos principais
Premium
